Source: Annals of Hepatology. Unidade: FM
Subjects: HEPATOPATIAS, CIRROSE HEPÁTICA, ÍNDICE DE MASSA CORPORAL, TRIAGEM DE MASSA
ABNT
DIAZ, Luis Antonio et al. Updated recommendations for the management of metabolic dysfunction-associated steatotic liver disease (MASLD) by the Latin American working group. Annals of Hepatology, v. 30, n. 2, 2025Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/88343. Acesso em: 19 abr. 2026.APA
Diaz, L. A., Arab, J. P., Idalsoaga, F., Perelli, J., Vega, J., Dirchwolf, M., et al. (2025). Updated recommendations for the management of metabolic dysfunction-associated steatotic liver disease (MASLD) by the Latin American working group. Annals of Hepatology, 30( 2). doi:10.1016/j.aohep.2025.101903NLM
Diaz LA, Arab JP, Idalsoaga F, Perelli J, Vega J, Dirchwolf M, Carreno J, Samith B, Valerio C, Oliveira CPMS de. Updated recommendations for the management of metabolic dysfunction-associated steatotic liver disease (MASLD) by the Latin American working group [Internet]. Annals of Hepatology. 2025 ; 30( 2):[citado 2026 abr. 19 ] Available from: https://observatorio.fm.usp.br/handle/OPI/88343Vancouver
Diaz LA, Arab JP, Idalsoaga F, Perelli J, Vega J, Dirchwolf M, Carreno J, Samith B, Valerio C, Oliveira CPMS de. Updated recommendations for the management of metabolic dysfunction-associated steatotic liver disease (MASLD) by the Latin American working group [Internet]. Annals of Hepatology. 2025 ; 30( 2):[citado 2026 abr. 19 ] Available from: https://observatorio.fm.usp.br/handle/OPI/88343
